Utilizing a murine model deficient in STAT6, we demonstrate that the IL-4/IL-13/STAT6-signaling pathway, which is a central component of the type 2 immune response, is rapidly activated during acute pancreatitis, thereby suppressing the pro-inflammatory reaction and dampening the inflammation-driven disease severity. This evidence concerns the gene IL13 and acute pancreatitis.